.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Expanding Role of CAR T Cells in Lymphoma and Leukemia

EP. 1: Rationale for Further Development of CAR T-Cell therapy

July 2nd 2020

EP. 2: CAR T-Cell Therapy in Managing Various Lymphomas

July 2nd 2020

EP. 3: R/R Large B-Cell Therapy in Managing Various Lymphomas

July 2nd 2020

EP. 4: The Importance of Antigen Loss in R/R Disease

July 2nd 2020

EP. 5: Liso-cel Therapy in R/R Large B-Cell Lymphoma

July 2nd 2020

EP. 6: LDH and ECOG Performance Tests

July 2nd 2020

EP. 7: ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact

July 2nd 2020

EP. 8: CAR T-Cell Therapy for Follicular Lymphoma

July 2nd 2020

EP. 9: R/R NHL: Candidate Identification and Referrals

July 2nd 2020

EP. 10: LBCL Therapy: The Right Therapy

July 2nd 2020

EP. 11: CAR T Cells and Lymphoma Adverse Events

July 2nd 2020

EP. 12: CAR T-Cell Therapy’s Future for Lymphoma

July 2nd 2020

EP. 13: Allogenic CAR T-Cell Therapy in Lymphoma

July 2nd 2020

EP. 14: Developing CAR T-Cell Trials

July 2nd 2020

EP. 15: Ongoing Issues in CAR T-Cell Therapy and Lymphoma

July 2nd 2020